Gordon-Alonso et al. [23] demonstrated that in melanoma with a dismal prognosis, Gal-3 binds the glycans of the extracellular matrix and of IFNγ, decreasing T-cell recruitment, which is the best predictor to date of patient survival [23]. Here, LGALS3 is linked to melanoma.